Theriva Biologics

Filed a patent for "microbiome protection from oral antibiotics" on Thu, August 15, 2024

Filed a patent for "treatment or prevention of gastrointestinal immunotherapy side effects" on Tue, August 9, 2022

Filed a patent for "microbiome protection from oral antibiotics" on Thu, August 31, 2023

Filed a patent for "e. coli-based production of beta-lactamase" on Thu, September 7, 2023

Filed a patent for "method and compositions for inhibiting or preventing adverse effects of oral antibiotics" on Thu, December 21, 2023

Filed a patent for "beta-lactamases with improved properties for therapy" on Thu, October 5, 2023

Filed a patent for "intestinal alkaline phosphatase formulations" on Thu, September 7, 2023

Filed a patent for "alkaline phosphatase agents for treatment of radiation disorders" on Thu, October 5, 2023

Filed a patent for "safe and effective beta-lactamase dosing for microbiome protection" on Thu, March 14, 2024

Filed a patent for "method and compositions for inhibiting or preventing adverse effects of oral antibiotics" on Thu, June 20, 2024